Oral Medication Shows Benefits Treating Type 1 Diabetes for at Least Two Years after Diagnosis

April 13, 2022

Use of the drug verapamil to treat type 1 diabetes continues to show benefits lasting at least two years, according to a recent report in Nature Communications. Patients taking the oral blood pressure medication not only required less daily insulin two years after first diagnosis of the disease, but also showed evidence of surprising immunomodulatory benefits. […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

Diabetes Product / Technology

←Introducing JCEM Case Reports and its Inaugural Editor-in-Chief

Stem Cells Show Promise in Treating Late-Onset Hypogonadism→

View Archives

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today